Pharyngitis — Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report — 2023 To 2033
Pharyngitis is a condition where the mucous membranes of the oropharynx become inflamed. The most common cause of pharyngitis is an infection, either bacterial or viral. Other less common causes include allergies, trauma, cancer, reflux, and certain toxins. Viral infections account for about 50% to 80% of pharyngitis cases. Various viral pathogens, including rhinovirus, influenza, adenovirus, coronavirus, and parainfluenza, cause these infections. Less common viral pathogens include herpes, Epstein-Barr virus, human immunodeficiency virus (HIV), and coxsackievirus. Bacterial infections are more severe and may develop after an initial viral infection. The most common bacterial infection is Group A beta-hemolytic streptococci, which causes 5% to 36% of cases of acute pharyngitis. Penicillin is the preferred antibiotic for treating Group A beta-hemolytic streptococcal (GAS) pharyngitis1. GAS pharyngitis is uncommon in preschool-aged children and adults. Group C and G beta-hemolytic Streptococcus causes pharyngitis in older children and adults. GAS pharyngitis causes 19.1 outpatient visits and 10.2 antibiotic prescriptions per 1000 US persons aged 0–64 years annually. GAS pharyngitis causes 93.2 visits and 53.2 antibiotic prescriptions per 1000 children ages 3–9 years annually, representing 5.9% of all outpatient antibiotic prescribing in this age group.
Thelansis’s “Pharyngitis Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report — 2023 To 2033” covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Pharyngitis treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).
KOLs insights of Pharyngitis across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.
Pharyngitis Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.
Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.
